UBS Downgrades Emerson (EMR) to Neutral on full valuation

October 3, 2023 12:34 AM EDT Send to a Friend
(Updated - October 3, 2023 5:47 AM EDT)

UBS analyst Chris Snyder downgraded Emerson (NYSE: EMR) from Buy to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login